Showing results (11-20 of 114) with videos related to
Sort By:
Pageof 12
Seminars in Hematology|March 16, 2024
Metabolic reprogramming in the CLL TME; potential for new therapeutic targetsHelga Simon-Molas, Chiara Montironi, Anna Kabanova, et al.Trends in Immunology|November 30, 2006
Withdrawal symptoms on display: Bcl-2 members under investigationNuno L Alves, René A W van Lier, Eric ElderingLeukemia|June 20, 2022
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphomaYvonne J Thus, Eric Eldering, Arnon P Kater, et al.International Journal of Molecular Sciences|September 6, 2019
Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic LeukemiaTom Hofland, Eric Eldering, Arnon P Kater, et al.Haematologica|March 11, 2021
T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspectiveFleur S Peters, Jonathan C Strefford, Eric Eldering, et al.Immunological Reviews|August 15, 2012
The fourth dimension in immunological space: how the struggle for nutrients selects high-affinity lymphocytesFelix M Wensveen, Klaas P J M van Gisbergen, Eric ElderingLeukemia Research|April 20, 2013
The biological rationale and clinical efficacy of inhibition of signaling kinases in chronic lymphocytic leukemiaIris de Weerdt, Eric Eldering, Marinus H van Oers, et al.Scientific Reports|October 21, 2016
Antigen-affinity controls pre-germinal center B cell selection by promoting Mcl-1 induction through BAFF receptor signalingFelix M Wensveen, Erik Slinger, Martijn Ha van Attekum, et al.The European Respiratory Journal|November 28, 2012
Effect of oxidative stress on respiratory epithelium from children with Down syndromeMartijn Bruijn, René Lutter, Eric Eldering, et al.The Journal of Biological Chemistry|May 1, 2004
Requirement for aspartate-cleaved bid in apoptosis signaling by DNA-damaging anti-cancer regimensArlette B Werner, Stephen W G Tait, Evert de Vries, et al.Pageof 12